Pfizer and BioNTech’s COVID-19 vaccine on Friday received authorization from the Food and Drug Administration (FDA) for children ages 5 to 11, Bloomberg News reports.
The vaccine is administered as a two-dose primary series, 3 weeks apart, but is a lower dose, 10 micrograms, than that used for individuals 12 years of age and older which is 30 micrograms.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)